Dr Ing Hc Stock Fundamentals
| DRPRF Stock | USD 61.80 0.28 0.45% |
Dr Ing hc fundamentals help investors to digest information that contributes to Dr Ing's financial success or failures. It also enables traders to predict the movement of DRPRF Pink Sheet. The fundamental analysis module provides a way to measure Dr Ing's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Dr Ing pink sheet.
DRPRF |
Dr Ing hc Company Shares Owned By Institutions Analysis
Dr Ing's Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
More About Shares Owned By Institutions | All Equity Analysis
Shares Held by Institutions | = | Funds and Banks | + | Firms |
Current Dr Ing Shares Owned By Institutions | 13.52 % |
Most of Dr Ing's fundamental indicators, such as Shares Owned By Institutions, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Dr Ing hc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
| Competition |
Based on the latest financial disclosure, 13.52% of Dr Ing hc are shares owned by institutions. This is 77.51% lower than that of the Consumer Cyclical sector and 13.94% lower than that of the Auto Manufacturers industry. The shares owned by institutions for all United States stocks is 65.52% higher than that of the company.
Dr Ing hc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Dr Ing's current stock value. Our valuation model uses many indicators to compare Dr Ing value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Dr Ing competition to find correlations between indicators driving Dr Ing's intrinsic value. More Info.Dr Ing hc is rated # 3 in profit margin category among its peers. It is rated # 2 in operating margin category among its peers reporting about 1.45 of Operating Margin per Profit Margin. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Dr Ing's earnings, one of the primary drivers of an investment's value.DRPRF Shares Owned By Institutions Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Dr Ing's direct or indirect competition against its Shares Owned By Institutions to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Dr Ing could also be used in its relative valuation, which is a method of valuing Dr Ing by comparing valuation metrics of similar companies.Dr Ing is currently under evaluation in shares owned by institutions category among its peers.
DRPRF Fundamentals
| Profit Margin | 0.14 % | |||
| Operating Margin | 0.20 % | |||
| Shares Owned By Insiders | 7.00 % | |||
| Shares Owned By Institutions | 13.52 % | |||
| Revenue | 36.76 B | |||
| Gross Profit | 8.99 B | |||
| EBITDA | 9.38 B | |||
| Net Income | 4.03 B | |||
| Cash And Equivalents | 5.87 B | |||
| Cash Per Share | 64.53 X | |||
| Total Debt | 9.75 B | |||
| Debt To Equity | 0.65 % | |||
| Current Ratio | 1.12 X | |||
| Book Value Per Share | 251.94 X | |||
| Cash Flow From Operations | 6.42 B | |||
| Number Of Employees | 36.52 K |
About Dr Ing Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Dr Ing hc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dr Ing using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dr Ing hc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Porsche AG engages in automotive and financial services businesses. Porsche AG operates as a subsidiary of Porsche Holding Stuttgart GmbH. Dr ING is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in DRPRF Pink Sheet
Dr Ing financial ratios help investors to determine whether DRPRF Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DRPRF with respect to the benefits of owning Dr Ing security.